%0 Journal Article %A Víctor M. Eguíluz %A Juan Fernández-Gracia %A Jorge P. Rodríguez %A Juan M. Pericás %A Carlos Melián %T Risk of secondary infection waves of COVID-19 in an insular region: the case of the Balearic Islands, Spain %D 2020 %R 10.1101/2020.05.03.20089623 %J medRxiv %P 2020.05.03.20089623 %X The Spanish government declared the lockdown on March 14th, 2020 to tackle the fast-spreading of COVID-19. As a consequence the Balearic Islands remained almost fully isolated due to the closing of airports and ports, These isolation measures and the home-based confinement have led to a low prevalence of COVID-19 in this region. We propose a compartmental model for the spread of COVID-19 including five compartments (Susceptible, Latent, Infected, Diseased, and Recovered), and the mobility between municipalities. The model parameters are calibrated with the temporal series of confirmed cases provided by the Spanish Ministry of Health. After calibration, the proposed model captures the trend of the official confirmed cases before and after the lockdown. We show that the estimated number of cases depends strongly on the initial dates of the local outbreak onset and the number of imported cases before the lockdown. Our estimations indicate that the population has not reached the level of herd immunization necessary to prevent future outbreaks. While the low prevalence, in comparison to mainland Spain, has prevented the saturation of the health system, this low prevalence translates into low immunization rates, therefore facilitating the propagation of new outbreaks that could lead to secondary waves of COVID-19 in the region. These findings warn about scenarios regarding after-lockdown-policies and the risk of second outbreaks, emphasize the need for widespread testing, and could potentially be extrapolated to other insular and continental regions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementV.M.E. and J.F.G. acknowledge funding from the Ministry of Science and Innovation (Spain) and FEDER through project SPASIMM [FIS2016-80067-P (AEI/FEDER, UE)]. JFG acknowledges funding through the postdoc program of the University of the Balearic Islands.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available as indicated in the main text. %U https://www.medrxiv.org/content/medrxiv/early/2020/05/08/2020.05.03.20089623.full.pdf